CN111655223A - 氨溴索改善皮肤屏障功能的用途 - Google Patents
氨溴索改善皮肤屏障功能的用途 Download PDFInfo
- Publication number
- CN111655223A CN111655223A CN201980009963.9A CN201980009963A CN111655223A CN 111655223 A CN111655223 A CN 111655223A CN 201980009963 A CN201980009963 A CN 201980009963A CN 111655223 A CN111655223 A CN 111655223A
- Authority
- CN
- China
- Prior art keywords
- skin
- ceramide
- reduce
- ambroxol
- appearance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862622375P | 2018-01-26 | 2018-01-26 | |
| US62/622,375 | 2018-01-26 | ||
| PCT/US2019/015137 WO2019147931A1 (en) | 2018-01-26 | 2019-01-25 | Use of ambroxol to improve skin barrier function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111655223A true CN111655223A (zh) | 2020-09-11 |
Family
ID=65363412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980009963.9A Pending CN111655223A (zh) | 2018-01-26 | 2019-01-25 | 氨溴索改善皮肤屏障功能的用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US10894008B2 (https=) |
| EP (1) | EP3743039A1 (https=) |
| JP (1) | JP7369716B2 (https=) |
| CN (1) | CN111655223A (https=) |
| CA (1) | CA3087079A1 (https=) |
| WO (1) | WO2019147931A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3654960A1 (en) * | 2017-07-16 | 2020-05-27 | Neuere, LLC | Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity |
| JP7369716B2 (ja) * | 2018-01-26 | 2023-10-26 | ノイレ, エルエルシー | 皮膚バリア機能を改善するためのアンブロキソールの使用 |
| WO2022098366A1 (en) * | 2020-11-09 | 2022-05-12 | Redwood Ip Holding, Llc | Skincare compositions for preventing transepidermal water loss |
| JPWO2023145735A1 (https=) * | 2022-01-25 | 2023-08-03 | ||
| CN121127451A (zh) * | 2023-05-02 | 2025-12-12 | 启威公司 | 一种用于医疗用途的改良型氨溴索 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020064524A1 (en) * | 1998-12-23 | 2002-05-30 | Gregor Cevc | Formulation for topical non-invasive application in vivo |
| CN1950076A (zh) * | 2004-05-03 | 2007-04-18 | 贝林格尔.英格海姆国际有限公司 | 含安溴索的局部制剂 |
| US20140161916A1 (en) * | 2012-12-11 | 2014-06-12 | Avon Products, Inc. | Method of Improving Aging Appearance of Skin by Modulation of WIPI-1 |
| CN105708870A (zh) * | 2011-11-30 | 2016-06-29 | Ibr以色列生物科技研究有限公司 | 可用于改善皮肤屏障功能的荷荷巴提取物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04002066A (es) | 2001-09-04 | 2005-02-17 | Techno Network Shinoku Co Ltd | Farmacos contra influenza. |
| DE10332487A1 (de) | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen |
| JP2008520630A (ja) * | 2004-11-22 | 2008-06-19 | シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト | 皮膚損傷に有効なセラミド及び/又は偽セラミドと(α−)ビサボロールを含む製剤 |
| ES2641272T3 (es) * | 2006-04-28 | 2017-11-08 | Children's Hospital Medical Center | Composiciones que comprenden proteínas o polipéptidos fusogénicos derivados de la prosaposina para aplicación en sistemas de suministro de fármacos transmembrana |
| WO2008021829A2 (en) * | 2006-08-09 | 2008-02-21 | Lipo Chemicals Inc. | Topical ceramide compositions and methos of use |
| JP5337405B2 (ja) | 2007-09-17 | 2013-11-06 | ザ・ホスピタル・フォー・シック・チルドレン | ゴーシェ病の治療方法 |
| US20110294833A1 (en) | 2010-05-26 | 2011-12-01 | Scripps Health | Methods for Healthy Aging |
| JP5938193B2 (ja) * | 2011-11-10 | 2016-06-22 | ポーラ化成工業株式会社 | 抗老化剤のスクリ−ニング方法 |
| JP2013241398A (ja) * | 2012-04-27 | 2013-12-05 | Fujifilm Corp | β−グルコセレブロシダーゼ活性増強剤、セラミド産生増強剤及び皮膚バリア機能改善剤 |
| US20180296464A1 (en) | 2017-04-17 | 2018-10-18 | W Skincare, LLC | Autophagy activation nutrient complex, compositions and methods |
| US10179095B2 (en) | 2017-06-07 | 2019-01-15 | Dr. Raymond Laboratories | Autophage activating resveratrol topical composition for skin improvement and treatment |
| EP3654960A1 (en) * | 2017-07-16 | 2020-05-27 | Neuere, LLC | Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity |
| JP7369716B2 (ja) * | 2018-01-26 | 2023-10-26 | ノイレ, エルエルシー | 皮膚バリア機能を改善するためのアンブロキソールの使用 |
-
2019
- 2019-01-25 JP JP2020561603A patent/JP7369716B2/ja active Active
- 2019-01-25 CN CN201980009963.9A patent/CN111655223A/zh active Pending
- 2019-01-25 EP EP19704532.1A patent/EP3743039A1/en active Pending
- 2019-01-25 CA CA3087079A patent/CA3087079A1/en active Pending
- 2019-01-25 WO PCT/US2019/015137 patent/WO2019147931A1/en not_active Ceased
- 2019-10-08 US US16/595,621 patent/US10894008B2/en active Active
-
2020
- 2020-12-17 US US17/124,798 patent/US11730690B2/en active Active
-
2023
- 2023-06-30 US US18/345,292 patent/US12390409B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020064524A1 (en) * | 1998-12-23 | 2002-05-30 | Gregor Cevc | Formulation for topical non-invasive application in vivo |
| CN1950076A (zh) * | 2004-05-03 | 2007-04-18 | 贝林格尔.英格海姆国际有限公司 | 含安溴索的局部制剂 |
| CN105708870A (zh) * | 2011-11-30 | 2016-06-29 | Ibr以色列生物科技研究有限公司 | 可用于改善皮肤屏障功能的荷荷巴提取物 |
| US20140161916A1 (en) * | 2012-12-11 | 2014-06-12 | Avon Products, Inc. | Method of Improving Aging Appearance of Skin by Modulation of WIPI-1 |
Non-Patent Citations (1)
| Title |
|---|
| HAORAN TAI ET AL: "Autophagy impairment with Iysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence", 《AUTOPHAGY》, vol. 13, no. 1, 28 October 2016 (2016-10-28), pages 99, XP055509900, DOI: 10.1080/15548627.2016.1247143 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3743039A1 (en) | 2020-12-02 |
| CA3087079A1 (en) | 2019-08-01 |
| JP2021511388A (ja) | 2021-05-06 |
| JP7369716B2 (ja) | 2023-10-26 |
| WO2019147931A1 (en) | 2019-08-01 |
| US12390409B2 (en) | 2025-08-19 |
| US20210128438A1 (en) | 2021-05-06 |
| US11730690B2 (en) | 2023-08-22 |
| US10894008B2 (en) | 2021-01-19 |
| US20200060955A1 (en) | 2020-02-27 |
| US20230346671A1 (en) | 2023-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12390409B2 (en) | Use of ambroxol to improve skin barrier function | |
| KR100876742B1 (ko) | 피부 건전화제 | |
| AU2012254214B2 (en) | A topical formulation for treatment of hyperkeratotic skin | |
| JP2020529980A (ja) | 皮膚の弛緩と身体の輪郭を改善するための組成物および方法 | |
| US20090053290A1 (en) | Transdermal drug delivery compositions and topical compositions for application on the skin | |
| JP2000514837A (ja) | 経皮浸透エンハンサーを使用する皮下筋肉組織へのカテコールアミン及び関連化合物の局所投与 | |
| CN105188650A (zh) | 基于水杨酸的舒缓化妆品组合物 | |
| AU2012254214A1 (en) | A topical formulation for treatment of hyperkeratotic skin | |
| WO2019104222A1 (en) | Methods and compositions for treatment of skin | |
| WO2001017499A1 (en) | Skin normalizing agents | |
| AU2019204136B2 (en) | Compositions and methods for treating skin conditions using light and glucosamine hydrochloride | |
| WO2013092872A2 (en) | Cosmetic processes with glucosamine-based hydrogels | |
| US5556887A (en) | Improved a palmitate composition for topical application which achieves to the entire dermal membrane. | |
| KR20100005538A (ko) | 피부 손상 치료용 조성물 | |
| TW202425945A (zh) | 硫乙胺組合物在與有機酸和/或氮苯-4-羧醯胺組合時用於皮膚再生及改善增效作用之用途 | |
| CN116507350A (zh) | 用于在影响皮肤屏障的皮肤病学手术中治疗性皮肤处理的方法和组合物 | |
| HK40098166A (zh) | 用於在影响皮肤屏障的皮肤病学手术中治疗性皮肤处理的方法和组合物 | |
| HK40051587A (en) | Nanofibre matrix for anti-pollution skin care | |
| CN112618381A (zh) | 用于抗污染皮肤护理的纳米纤维基质 | |
| BR102019013368B1 (pt) | Composição tópica compreendendo cloridrato de glicosamin, métodos para tratamento da pele e para aumentar a produção de ácido hialurônico pela pele usando luz e cloridrato de glicosamina e filme | |
| MARIE LODEN | The Skin Barrier and Use of Moisturizers in Atopic Dermatitis | |
| BR102017010608B1 (pt) | Composição cosmética, método para o cuidado da pele, uso cosmético e produto cosmético para o cuidado da pele | |
| BRPI1107447A2 (pt) | Composição cosmética, kit para tratamento da pele, método para tratar pele oleosa ou mista ou pele com acne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |